Figure 1
Figure 1. Evaluation of PMN apoptosis in the presence of cytokine-activated NK-cell supernatant. (A) PMNs were cultured in the absence (Med) or presence (NK + IL-2) of IL-2–activated NK-cell supernatant, and stained with annexin and viaprobe to determine apoptosis. Annexin+viaprobe− cells (top left quadrant) were defined as apoptotic and annexin−viaprobe− cells (bottom left quadrant) as living. (B) The percentage of apoptotic PMNs was determined at different time points in the absence (Med) or presence (NK + IL-2) of IL-2–activated NK-cell supernatant (n= 1). The data points represent the percentage of apoptotic PMNs when cultured alone or with supernatants from cytokine-activated NK cells. (C) Quantitative representation of the percentage of apoptotic PMNs when cultured alone (Med) or with supernatants from unstimulated (NK sup) or IL-2–activated (NK + IL-2 sup) NK cells for 18-24 hours, from 24 individual experiments totally. (D) PMNs cultured with supernatants from NK cells stimulated with IL-2, IL-21, IL-15, IL-12, IL-18, or a combination of IL-12 plus IL-18 compared with control medium (Med) and PMNs treated with cytokines alone (n= 5). The results are expressed as mean ± SEM. ***P < .001.

Evaluation of PMN apoptosis in the presence of cytokine-activated NK-cell supernatant. (A) PMNs were cultured in the absence (Med) or presence (NK + IL-2) of IL-2–activated NK-cell supernatant, and stained with annexin and viaprobe to determine apoptosis. Annexin+viaprobe cells (top left quadrant) were defined as apoptotic and annexinviaprobe cells (bottom left quadrant) as living. (B) The percentage of apoptotic PMNs was determined at different time points in the absence (Med) or presence (NK + IL-2) of IL-2–activated NK-cell supernatant (n= 1). The data points represent the percentage of apoptotic PMNs when cultured alone or with supernatants from cytokine-activated NK cells. (C) Quantitative representation of the percentage of apoptotic PMNs when cultured alone (Med) or with supernatants from unstimulated (NK sup) or IL-2–activated (NK + IL-2 sup) NK cells for 18-24 hours, from 24 individual experiments totally. (D) PMNs cultured with supernatants from NK cells stimulated with IL-2, IL-21, IL-15, IL-12, IL-18, or a combination of IL-12 plus IL-18 compared with control medium (Med) and PMNs treated with cytokines alone (n= 5). The results are expressed as mean ± SEM. ***P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal